RU2018102372A3 - - Google Patents

Download PDF

Info

Publication number
RU2018102372A3
RU2018102372A3 RU2018102372A RU2018102372A RU2018102372A3 RU 2018102372 A3 RU2018102372 A3 RU 2018102372A3 RU 2018102372 A RU2018102372 A RU 2018102372A RU 2018102372 A RU2018102372 A RU 2018102372A RU 2018102372 A3 RU2018102372 A3 RU 2018102372A3
Authority
RU
Russia
Application number
RU2018102372A
Other versions
RU2018102372A (ru
RU2747673C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018102372A publication Critical patent/RU2018102372A/ru
Publication of RU2018102372A3 publication Critical patent/RU2018102372A3/ru
Application granted granted Critical
Publication of RU2747673C2 publication Critical patent/RU2747673C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2018102372A 2015-06-23 2016-06-22 Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их RU2747673C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1555747 2015-06-23
FR1555747A FR3037956B1 (fr) 2015-06-23 2015-06-23 Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2016/064436 WO2016207226A1 (en) 2015-06-23 2016-06-22 New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
RU2018102372A RU2018102372A (ru) 2019-07-23
RU2018102372A3 true RU2018102372A3 (ru) 2019-11-06
RU2747673C2 RU2747673C2 (ru) 2021-05-12

Family

ID=54260901

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018102372A RU2747673C2 (ru) 2015-06-23 2016-06-22 Новые аминокислотные производные, способ их получения и фармацевтические композиции, содержащие их

Country Status (42)

Country Link
US (1) US10457687B2 (ru)
EP (1) EP3313850B1 (ru)
JP (1) JP6741698B2 (ru)
KR (1) KR102620905B1 (ru)
CN (1) CN107709334B (ru)
AR (1) AR105101A1 (ru)
AU (1) AU2016282837B2 (ru)
CA (1) CA2990089C (ru)
CL (1) CL2017003163A1 (ru)
CO (1) CO2017012830A2 (ru)
CR (2) CR20170590A (ru)
CU (1) CU20170164A7 (ru)
CY (1) CY1120991T1 (ru)
DK (1) DK3313850T3 (ru)
EA (1) EA034587B1 (ru)
EC (1) ECSP17082546A (ru)
ES (1) ES2703997T3 (ru)
FR (1) FR3037956B1 (ru)
GE (1) GEP20207075B (ru)
HK (2) HK1250234A1 (ru)
HR (1) HRP20181806T1 (ru)
IL (1) IL256191B (ru)
JO (1) JO3430B1 (ru)
LT (1) LT3313850T (ru)
MA (1) MA42232B1 (ru)
MD (1) MD3313850T2 (ru)
MX (1) MX368845B (ru)
MY (1) MY189472A (ru)
PE (1) PE20190111A1 (ru)
PH (1) PH12017502266A1 (ru)
PL (1) PL3313850T3 (ru)
PT (1) PT3313850T (ru)
RS (1) RS57961B1 (ru)
RU (1) RU2747673C2 (ru)
SA (1) SA517390583B1 (ru)
SI (1) SI3313850T1 (ru)
SV (1) SV2017005588A (ru)
TN (1) TN2017000521A1 (ru)
TW (1) TWI631124B (ru)
UA (1) UA123267C2 (ru)
UY (1) UY36733A (ru)
WO (1) WO2016207226A1 (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY37342A (es) 2016-07-22 2018-01-31 Servier Lab Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
UY37560A (es) 2017-01-06 2018-07-31 Servier Lab Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta
AU2018205735B2 (en) * 2017-01-06 2024-02-01 Les Laboratoires Servier Combination of a MCL-1 inhibitor and a taxane compound, uses and pharmaceutical compositions thereof
BR112019026959A2 (pt) 2017-06-22 2020-07-07 Les Laboratoires Servier combinação de um inibidor de mcl-1 e um tratamento com padrão de atendimento para cânceres hematológicos, seus usos e composições farmacêuticas
CA3073112A1 (en) 2017-08-15 2019-02-21 Abbvie Inc. Macrocyclic mcl-1 inhibitors and methods of use
BR112020003163A2 (pt) * 2017-08-15 2020-09-15 AbbVie Deutschland GmbH & Co. KG inibidores macrocíclicos de mcl-1 e métodos de uso
CN110964034B (zh) * 2018-09-29 2022-04-12 江苏恒瑞医药股份有限公司 嘧啶并噻吩类衍生物、其制备方法及其在医药上的应用
AR116635A1 (es) 2018-10-15 2021-05-26 Servier Lab Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen
CA3119395A1 (en) 2018-11-14 2020-05-22 Les Laboratoires Servier Combination of a mcl-1 inhibitor and midostaurin, uses and pharmaceutical compositions thereof
CN111187277B (zh) * 2018-11-14 2022-04-12 江苏恒瑞医药股份有限公司 噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
JOP20210289A1 (ar) 2019-05-20 2023-01-30 Servier Lab مقترنات عقار - جسم مضاد مثبط لـmcl-1 وطرق لاستخدامها
WO2020254299A1 (en) 2019-06-17 2020-12-24 Les Laboratoires Servier Combination of a mcl-1 inhibitor and a standard of care treatment for breast cancer, uses and pharmaceutical compositions thereof
CN112457308B (zh) 2019-09-09 2024-01-02 上海长森药业有限公司 新型三环芳香杂环化合物,及其制备方法、药物组合物和应用
IL303079A (en) 2020-11-24 2023-07-01 Novartis Ag Antibody-drug conjugates inhibiting MCL-1 and methods of using them
CA3222269A1 (en) 2021-06-11 2022-12-15 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-cancer agents
EP4351657A1 (en) 2021-06-11 2024-04-17 Gilead Sciences, Inc. Combination mcl-1 inhibitors with anti-body drug conjugates
AR129380A1 (es) 2022-05-20 2024-08-21 Novartis Ag Conjugados de anticuerpo-fármaco de compuestos antineoplásicos y métodos de uso de los mismos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96531A (en) * 1989-12-11 1995-08-31 Univ Princeton History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
DE10058663A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Thienopyrimidinen
WO2007056214A2 (en) * 2005-11-02 2007-05-18 Cytovia, Inc N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof
CN102014627B (zh) * 2008-04-30 2014-10-29 国家卫生研究院 作为极光激酶抑制剂的稠合双环嘧啶化合物
WO2012044993A1 (en) * 2010-09-30 2012-04-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
CN102464667B (zh) * 2010-11-03 2014-06-04 中国科学院上海药物研究所 一类五元杂环并嘧啶类化合物及其制备方法和用途
EP2655377B1 (en) * 2010-12-20 2016-03-30 Glenmark Pharmaceuticals S.A. 2-amino-4-arylthiazole compounds as trpa1 antagonists
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
FR2986002B1 (fr) * 2012-01-24 2014-02-21 Servier Lab Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20150307532A1 (en) 2012-11-20 2015-10-29 The Royal Institution For The Advancement Of Learning/Mcgill University Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037959B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037957B1 (fr) * 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3046792B1 (fr) * 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
IL256191B (en) 2020-03-31
MX2017016996A (es) 2018-08-23
MY189472A (en) 2022-02-16
CR20170571A (es) 2018-02-20
AR105101A1 (es) 2017-09-06
PH12017502266B1 (en) 2018-06-11
MD3313850T2 (ro) 2019-02-28
IL256191A (en) 2018-02-28
RS57961B1 (sr) 2019-01-31
TW201712018A (zh) 2017-04-01
SA517390583B1 (ar) 2022-02-20
MX368845B (es) 2019-10-18
AU2016282837B2 (en) 2020-05-28
JP6741698B2 (ja) 2020-08-19
HK1252113A1 (zh) 2019-05-17
CA2990089C (en) 2020-11-03
EA034587B1 (ru) 2020-02-25
PH12017502266A1 (en) 2018-06-11
SV2017005588A (es) 2018-06-01
CA2990089A1 (en) 2016-12-29
TWI631124B (zh) 2018-08-01
US10457687B2 (en) 2019-10-29
CN107709334A (zh) 2018-02-16
MA42232B1 (fr) 2018-11-30
TN2017000521A1 (en) 2019-04-12
ECSP17082546A (es) 2018-02-28
WO2016207226A1 (en) 2016-12-29
PL3313850T3 (pl) 2019-04-30
KR20180015261A (ko) 2018-02-12
PE20190111A1 (es) 2019-01-15
CL2017003163A1 (es) 2018-06-15
RU2018102372A (ru) 2019-07-23
US20190031675A1 (en) 2019-01-31
PT3313850T (pt) 2018-11-29
UA123267C2 (uk) 2021-03-10
FR3037956B1 (fr) 2017-08-04
JP2018522856A (ja) 2018-08-16
CO2017012830A2 (es) 2018-03-28
GEP20207075B (en) 2020-03-10
DK3313850T3 (en) 2019-01-28
EP3313850A1 (en) 2018-05-02
LT3313850T (lt) 2018-11-26
HK1250234A1 (zh) 2018-12-07
JO3430B1 (ar) 2019-10-20
CY1120991T1 (el) 2019-12-11
EP3313850B1 (en) 2018-10-03
BR112017027645A2 (pt) 2018-08-28
HRP20181806T1 (hr) 2018-12-28
CR20170590A (es) 2018-02-26
HK1252113B (zh) 2020-01-10
MA42232A (fr) 2016-12-29
CN107709334B (zh) 2021-04-13
AU2016282837A1 (en) 2018-01-18
FR3037956A1 (ru) 2016-12-30
EA201890123A1 (ru) 2018-05-31
CU20170164A7 (es) 2018-05-08
UY36733A (es) 2016-12-30
KR102620905B1 (ko) 2024-01-04
ES2703997T3 (es) 2019-03-13
SI3313850T1 (sl) 2019-01-31
RU2747673C2 (ru) 2021-05-12

Similar Documents

Publication Publication Date Title
RU2018102372A3 (ru)
BR112017026365A2 (ru)
BE2015C047I2 (ru)
BE2015C044I2 (ru)
BR0003686B1 (ru)
BR0008158B1 (ru)
BR9906949B1 (ru)
BR0007834B1 (ru)
BR0007747B1 (ru)
BR0008132B1 (ru)
BR0000126B1 (ru)
BR0000695B1 (ru)
BR0000763F1 (ru)
BR0001536B1 (ru)
BR0001684B1 (ru)
BR0001810B1 (ru)
BR0002033B1 (ru)
BR0007672B1 (ru)
BR0002402B1 (ru)
BR0002435B1 (ru)
BR0009349B1 (ru)
BR0009649B1 (ru)
BR0009717B1 (ru)
BR0009182B1 (ru)
BR0009757B1 (ru)